Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 14, 2018
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
[ Fri, Sep 14th 2018
] - WOPRAI
Thu, September 13, 2018
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
Madhu Kumar Maintained (APLS) at Strong Buy with Increased Target to $40 on, Sep 13th, 2018
Madhu Kumar of B. Riley Securities, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $27 to $40 on, Sep 13th, 2018.
Madhu has made no other calls on APLS in the last 4 months.
There is 1 other peer that has a rating on APLS. Out of the 1 peers that are also analyzing APLS, 0 agree with Madhu's Rating of Hold.
This is the rating of the analyst that currently disagrees with Madhu
- Elemer Piros of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $53 on, Wednesday, August 8th, 2018
